Delivery Order 75N93021D00010-75N93021F00001
- The Southern Research Institute has been awarded a $12,640.21 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this cost-plus-fixed-fee task order, Southern Research will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics. The work will be...
- Southern Research Institute, a non-profit biomedical research organization based in Birmingham, Alabama, has received a delivery order valued at $403,478 under the National Institute of Allergy and Infectious Diseases (NIAID) "Preclinical Services for HIV Therapeutics" Indefinite Delivery/Indefinite Quantity (IDIQ) master contract. The delivery order, awarded on September 1, 2023, with an ultimate completion date of August 31, 2026, tasks Southern Research with conducting hit-to-lead...
- This task order, awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract held by The University of Iowa. The purpose of this $0.00 delivery order is to provide preclinical services in support of developing therapeutics to treat HIV/AIDS. Set to be completed by May 2021, this award draws from the potential $0...
- This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Southern Research Institute on July 26, 2018, with a ceiling value of $174,999, under a parent IDIQ for in vitro testing of HIV therapeutic agents and topical microbicides. The contractor will test interventional agents in standard-format cell culture assays (96 or fewer wells) to identify and characterize compounds that block HIV infection, inhibit HIV gene expression and replication, or cure infected cells....
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Southern Research Institute on July 26, 2018, with a ceiling value of $499,816.00 for optimization, development, and synthesis of lead candidates and analogs for HIV therapeutics and topical microbicides, including resynthesis, acquisition, or purchase of compounds. Place of performance is Birmingham, AL. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 31, 2019. The...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, valued at $275,547.00, is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for providing preclinical services related to the development of HIV therapeutics and topical microbicides. The work to be performed under...
- This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle held by Sri International. The National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services' National Institutes of Health, awarded this $0 delivery order against the multiple award indefinite delivery/indefinite quantity master contract. Sri International will perform preclinical services in West Menlo Park, California in...
- Southern Research Institute was awarded a $749,998 cost-plus-fixed-fee delivery order against the In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). Under this delivery order, Southern Research will carry out activities to optimize, develop, and synthesize lead anti-HIV candidates and analogs, including resynthesis, acquisition, or...
- This is a cost-plus-fixed-fee delivery order awarded to Southern Research Institute by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $404,140 contract is to conduct hit-to-lead progression studies on interventional agents for the identification of anti-HIV lead compounds under the agency's Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. The contract has no set-aside...
- Preclinical Services for HIV TherapeuticsMaster IDIQ
- 75N93021D00010Indefinite Delivery Contract
- 75N93021D00010-75N93021F00001Delivery Order
This task order, awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Southern Research Institute, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle. The purpose of this delivery order is to provide preclinical services in support of HIV therapeutics research and development efforts. With a potential value of $0.00 and cost-no-fee pricing, this task order draws from the larger Preclinical Services for HIV Therapeutics multiple award IDIQ located in Birmingham, Alabama, which supports the National Institute of Allergy and Infectious Diseases' goal of developing effective treatments and a cure for HIV/AIDS. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($2k) | 5/24/21 | |
| Not listed | Not listed | $2.5k | 10/14/20 |